GEHC GE HealthCare (GEHC) Q4 FY25 earnings call
GE HealthCare delivered strong Q4 FY25 financial performance, exceeding expectations with robust organic revenue growth in Pharmaceutical Diagnostics, Imaging, and Advanced Visualization Solutions. The company achieved a record backlog and solid free cash flow, driven by a strong innovation pipeline and strategic initiatives like the Heartbeat business system. While navigating tariff headwinds and a cautious outlook on China, management remains confident in its midterm targets, supported by new product launches and strategic M&A.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
GEHC operating KPIs by quarter
| KPI | Dec 2024 Q4 FY24 | Mar 2025 Q1 FY25 | Jun 2025 Q2 FY25 | Sep 2025 Q3 FY25 | This call Dec 2025 Q4 FY25 | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|---|---|---|---|---|
| Book-to-bill | 1.09 ratioOrder dollars continued to outpace sales, helping us deliver strong total company book-to-bill of 1.09x, our highest since the spin.Source: earnings call transcript | 1.09 ratioBook-to-bill in the quarter was strong at 1.09x.Source: earnings call transcript | 1.07 ratioBook-to-bill for the quarter was strong at 1.07x, and we exited the quarter with a record backlog of $21.3 billion.Source: earnings call transcript | 1.06 ratioWe delivered strong book-to-bill at 1.06x, and we exited the quarter with a solid backlog at $21.2 billion.Source: earnings call transcript | 1.06 ratioWe exited the quarter with a record backlog of $21.8 billion, which grew $2 billion year-over-year and $600 million sequentially, and we delivered a book-to-bill ratio of 1.06x.Source: earnings call transcript | 1.07 ratioWe delivered a solid book-to-bill at 1.07x, and we exited the quarter with a record backlog of $21.8 billion, up $1.2 billion year-over-year.Source: earnings call transcript | 1.15 ratioOrders increased 11% and with strong backlog, which grew $2.6 billion year-over-year and book-to-bill of 1.15x, all of which were at record levels.Source: earnings call transcript | +7.5% |
| Backlog | $19.8BWe exited the fourth quarter with a record backlog of $19.8 billion, up $700 million year-over-year and up $200 million sequentially.Source: earnings call transcript | $20.6BWe also exited the quarter with a record backlog of $20.6 billion, up $1.9 billion year-over-year and also up $800 million sequentially.Source: earnings call transcript | $21.3BBook-to-bill for the quarter was strong at 1.07x, and we exited the quarter with a record backlog of $21.3 billion.Source: earnings call transcript | $21.2BWe delivered strong book-to-bill at 1.06x, and we exited the quarter with a solid backlog at $21.2 billion.Source: earnings call transcript | $21.8BWe exited the quarter with a record backlog of $21.8 billion, which grew $2 billion year-over-year and $600 million sequentially, and we delivered a book-to-bill ratio of 1.06x.Source: earnings call transcript | $21.8BWe delivered a solid book-to-bill at 1.07x, and we exited the quarter with a record backlog of $21.8 billion, up $1.2 billion year-over-year.Source: earnings call transcript | $23.9BBook-to-bill was 1.15x, also our highest since the spend, and we exited the quarter with a record backlog of $23.9 billion, up $2.6 billion year-over-year and $2.1 billion sequentially.Source: earnings call transcript | +9.6% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.